Insulet Corporation - Common Stock (NQ:PODD)

295.19 +0.99 (+0.34%)

Streaming Delayed Price Updated: 4:00 PM EST, Dec 10, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Insulet Corporation - Common Stock

< Previous 1 2

...

12 13 14 15 16 17 18 19 Next >

Insulet Announces Omnipod® 5 Automated Insulin Delivery System is Now Available in the United Kingdom

June 20, 2023

From Insulet Corporation

Via Business Wire

Expert Ratings for Insulet ↗

May 30, 2023

Via Benzinga

Medtronic's EOflow Acquisition Will Not Impact Insulet's Omnipod' Insulin Pump In Near or Medium Term: Analyst ↗

May 26, 2023

Via Benzinga

Insulet Earnings Perspective: Return On Capital Employed ↗

May 17, 2023

Via Benzinga

AMD Stock, AI Play And New S&P 500 Member Lead 5 Stocks Near Buy Points ↗

May 06, 2023

AMD and a new S&P 500 member lead this weekend's watch list.

Via Investor's Business Daily

Recap: Insulet Q1 Earnings ↗

May 04, 2023

Via Benzinga

4 Analysts Have This to Say About Insulet ↗

April 17, 2023

Via Benzinga

Analyst Expectations for Insulet's Future ↗

February 24, 2023

Via Benzinga

Preview: Insulet's Earnings ↗

February 22, 2023

Via Benzinga

Insulet Reports Better-Than-Expected Q1 Earnings As Omnipod 5 Launch Gains Momentum, Lifts Guidance ↗

May 05, 2023

Via Benzinga

Insulet Announces New Organizational Structure to Drive Further Growth

May 04, 2023

From Insulet Corporation

Via Business Wire

Insulet Reports First Quarter 2023 Revenue Increase of 21% Year-Over-Year (23% Constant Currency1)

May 04, 2023

From Insulet Corporation

Via Business Wire

Insulet Publishes 2022 Sustainability Report Focused on Innovating for the Future and Preserving the Environment

May 02, 2023

From Insulet Corporation

Via Business Wire

Insulet Announces FDA Clearance of Omnipod GO™, a First-of-its-Kind Basal-Only Insulin Pod, Further Simplifying Life for People with Type 2 Diabetes

April 25, 2023

From Insulet Corporation

Via Business Wire

5 S&P 500 Stocks Showing Strength As Recession Fears Rise ↗

April 07, 2023

Medical stocks are holding up amid economic and market uncertainty.

Via Investor's Business Daily

Insulet to Announce First Quarter 2023 Financial Results on May 4, 2023

March 30, 2023

From Insulet Corporation

Via Business Wire

CORRECTING and REPLACING Insulet Reports Full Year 2022 Revenue Increase of 19% (22% constant currency1) and Fourth Quarter 2022 Revenue Increase of 20% Year-Over-Year (24% constant currency)

February 24, 2023

From Insulet Corporation

Via Business Wire

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

February 23, 2023

Via Benzinga

Highly Anticipated Omnipod® 5 Real-World Evidence to be Presented at the 16th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD)

February 21, 2023

From Insulet Corporation

Via Business Wire

3 Growth Stocks That Have Delivered 10X Returns Over the Past Decade ↗

February 14, 2023

Are these stocks still good buys today?

Via The Motley Fool

Insulet Acquires Assets of Automated Glucose Control LLC (AGC)

February 14, 2023

From Insulet Corporation

Via Business Wire

Earnings Scheduled For February 23, 2023 ↗

February 23, 2023

Companies Reporting Before The Bell • ChipMOS TECHNOLOGIES (NASDAQ:IMOS) is likely to report earnings for its fourth quarter.

Via Benzinga

Insulet to Present at Upcoming Investor Conferences

February 14, 2023

From Insulet Corporation

Via Business Wire

Insulet Acquires Insulin Pump Patents from Bigfoot Biomedical as Both Companies Prioritize Improved Insulin Delivery Technologies

February 13, 2023

From Insulet Corporation

Via Business Wire

The 7 Best Tech Stocks to Buy for February 2023 ↗

February 09, 2023

Some of the best tech stocks are looking increasingly attractive as the worst fears fail to materialize. Here are seven to consider.

Via InvestorPlace

Benzinga's Top Ratings Upgrades, Downgrades For January 26, 2023 ↗

January 26, 2023

Via Benzinga

Insulet Has Potential To Gain More Than Analysts Are Forecasting

January 18, 2023

Even as it pulled back with the broader market Tuesday, insulin pump maker Insulet found support along its 50-day line and remained in possible buy range.

Via MarketBeat

Insulet to Announce Fourth Quarter and Full Year 2022 Financial Results on February 23, 2023

January 12, 2023

From Insulet Corporation

Via Business Wire

10 Health Care Stocks Whale Activity In Today's Session ↗

December 23, 2022

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...

Via Benzinga

Dow Jones Giant UnitedHealth Among 5 Resilient Stocks In Sickly Market Rally ↗

December 17, 2022

UnitedHealth is among medical stocks holding key support.

Via Investor's Business Daily

< Previous 1 2

...

12 13 14 15 16 17 18 19 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.